AAPL340.97+4.33 (+1.29%) ▲|ABBV281.12+4.65 (+1.68%) ▲|ABT101.82+2.22 (+2.23%) ▲|ACN214.87+5.81 (+2.78%) ▲|ADBE238.14-4.13 (-1.70%) ▼|AMAT497.53-9.50 (-1.87%) ▼|AMD594.24-13.86 (-2.28%) ▼|AMGN417.57+2.70 (+0.65%) ▲|AMT182.56+0.32 (+0.18%) ▲|AMZN259.53-2.90 (-1.11%) ▼|AVGO354.73-6.81 (-1.88%) ▼|AXP311.53+3.36 (+1.09%) ▲|BA189.50-0.87 (-0.46%) ▼|BAC54.58+0.26 (+0.48%) ▲|BKNG158.43-1.91 (-1.19%) ▼|BLK1,083.92+1.53 (+0.14%) ▲|BMY57.58-1.54 (-2.60%) ▼|BNY142.85+0.14 (+0.10%) ▲|BRK-B517.60+1.98 (+0.38%) ▲|C131.92+2.28 (+1.76%) ▲|CAT799.37-1.10 (-0.14%) ▼|CL89.98+1.71 (+1.94%) ▲|CMCSA20.68+0.02 (+0.10%) ▲|COF201.14+1.88 (+0.94%) ▲|COP137.56+3.46 (+2.58%) ▲|COST959.44+12.52 (+1.32%) ▲|CRM233.92+4.79 (+2.09%) ▲|CSCO115.34-3.05 (-2.58%) ▼|CVS87.74+1.58 (+1.83%) ▲|CVX215.00+3.02 (+1.42%) ▲|DE632.61+11.68 (+1.88%) ▲|DHR221.20+1.39 (+0.63%) ▲|DIS108.49+0.44 (+0.41%) ▲|DUK117.69+1.04 (+0.89%) ▲|EMR162.46+0.63 (+0.39%) ▲|FDX292.23+0.52 (+0.18%) ▲|GD335.46+4.19 (+1.26%) ▲|GE308.64+0.44 (+0.14%) ▲|GEV996.80-7.93 (-0.79%) ▼|GILD150.43-0.74 (-0.49%) ▼|GM82.37-0.36 (-0.44%) ▼|GOOG348.97+1.11 (+0.32%) ▲|GOOGL352.72+1.06 (+0.30%) ▲|GS893.95-1.37 (-0.15%) ▼|HD290.62-0.12 (-0.04%) ▼|HON209.64+1.91 (+0.92%) ▲|IBM227.02-0.11 (-0.05%) ▼|INTC101.35-3.35 (-3.20%) ▼|INTU305.99+3.24 (+1.07%) ▲|ISRG427.64+3.68 (+0.87%) ▲|JNJ263.73+2.29 (+0.88%) ▲|JPM334.30+1.31 (+0.39%) ▲|KO89.79+1.74 (+1.98%) ▲|LIN487.35+3.62 (+0.75%) ▲|LLY1,182.62+3.35 (+0.28%) ▲|LMT511.88+2.29 (+0.45%) ▲|LOW185.57-0.43 (-0.23%) ▼|LRCX309.56-9.28 (-2.91%) ▼|MA595.09+5.95 (+1.01%) ▲|MCD235.65+0.42 (+0.18%) ▲|MDLZ61.79+1.38 (+2.28%) ▲|MDT91.93+3.45 (+3.90%) ▲|META742.96+24.29 (+3.38%) ▲|MMM160.89+0.93 (+0.58%) ▲|MO71.66-0.02 (-0.03%) ▼|MRK145.45-0.15 (-0.10%) ▼|MS190.02+0.00 (+0.00%) ▲|MSFT541.15+6.08 (+1.14%) ▲|MU989.04-39.96 (-3.88%) ▼|NEE78.51+1.13 (+1.46%) ▲|NFLX70.61+0.31 (+0.44%) ▲|NKE35.35+0.64 (+1.84%) ▲|NOW140.32-0.54 (-0.38%) ▼|NVDA226.32-2.96 (-1.29%) ▼|ORCL137.39-4.01 (-2.84%) ▼|PEP126.68+0.71 (+0.56%) ▲|PFE28.40+0.12 (+0.42%) ▲|PG153.20+1.97 (+1.30%) ▲|PLTR209.00-0.05 (-0.02%) ▼|PM202.00+0.81 (+0.40%) ▲|QCOM174.43-1.07 (-0.61%) ▼|RTX186.66+0.69 (+0.37%) ▲|SBUX92.29+1.54 (+1.69%) ▲|SCHW97.06+0.36 (+0.37%) ▲|SO87.04+0.87 (+1.01%) ▲|SPG201.41+1.99 (+1.00%) ▲|T22.49+0.31 (+1.40%) ▲|TMO662.24+4.22 (+0.64%) ▲|TMUS151.87+3.29 (+2.21%) ▲|TSLA378.03-4.67 (-1.22%) ▼|TXN281.74-2.00 (-0.70%) ▼|UBER71.50-0.01 (-0.01%) ▼|UNH378.52-0.78 (-0.21%) ▼|UNP281.57+3.23 (+1.16%) ▲|UPS95.34+0.77 (+0.81%) ▲|USB57.42+0.34 (+0.60%) ▲|V389.27+3.82 (+0.99%) ▲|VZ42.78+1.13 (+2.71%) ▲|WFC83.32-0.23 (-0.28%) ▼|WMT113.08+1.73 (+1.55%) ▲|XOM172.15+3.21 (+1.90%) ▲|AAPL340.97+4.33 (+1.29%) ▲|ABBV281.12+4.65 (+1.68%) ▲|ABT101.82+2.22 (+2.23%) ▲|ACN214.87+5.81 (+2.78%) ▲|ADBE238.14-4.13 (-1.70%) ▼|AMAT497.53-9.50 (-1.87%) ▼|AMD594.24-13.86 (-2.28%) ▼|AMGN417.57+2.70 (+0.65%) ▲|AMT182.56+0.32 (+0.18%) ▲|AMZN259.53-2.90 (-1.11%) ▼|AVGO354.73-6.81 (-1.88%) ▼|AXP311.53+3.36 (+1.09%) ▲|BA189.50-0.87 (-0.46%) ▼|BAC54.58+0.26 (+0.48%) ▲|BKNG158.43-1.91 (-1.19%) ▼|BLK1,083.92+1.53 (+0.14%) ▲|BMY57.58-1.54 (-2.60%) ▼|BNY142.85+0.14 (+0.10%) ▲|BRK-B517.60+1.98 (+0.38%) ▲|C131.92+2.28 (+1.76%) ▲|CAT799.37-1.10 (-0.14%) ▼|CL89.98+1.71 (+1.94%) ▲|CMCSA20.68+0.02 (+0.10%) ▲|COF201.14+1.88 (+0.94%) ▲|COP137.56+3.46 (+2.58%) ▲|COST959.44+12.52 (+1.32%) ▲|CRM233.92+4.79 (+2.09%) ▲|CSCO115.34-3.05 (-2.58%) ▼|CVS87.74+1.58 (+1.83%) ▲|CVX215.00+3.02 (+1.42%) ▲|DE632.61+11.68 (+1.88%) ▲|DHR221.20+1.39 (+0.63%) ▲|DIS108.49+0.44 (+0.41%) ▲|DUK117.69+1.04 (+0.89%) ▲|EMR162.46+0.63 (+0.39%) ▲|FDX292.23+0.52 (+0.18%) ▲|GD335.46+4.19 (+1.26%) ▲|GE308.64+0.44 (+0.14%) ▲|GEV996.80-7.93 (-0.79%) ▼|GILD150.43-0.74 (-0.49%) ▼|GM82.37-0.36 (-0.44%) ▼|GOOG348.97+1.11 (+0.32%) ▲|GOOGL352.72+1.06 (+0.30%) ▲|GS893.95-1.37 (-0.15%) ▼|HD290.62-0.12 (-0.04%) ▼|HON209.64+1.91 (+0.92%) ▲|IBM227.02-0.11 (-0.05%) ▼|INTC101.35-3.35 (-3.20%) ▼|INTU305.99+3.24 (+1.07%) ▲|ISRG427.64+3.68 (+0.87%) ▲|JNJ263.73+2.29 (+0.88%) ▲|JPM334.30+1.31 (+0.39%) ▲|KO89.79+1.74 (+1.98%) ▲|LIN487.35+3.62 (+0.75%) ▲|LLY1,182.62+3.35 (+0.28%) ▲|LMT511.88+2.29 (+0.45%) ▲|LOW185.57-0.43 (-0.23%) ▼|LRCX309.56-9.28 (-2.91%) ▼|MA595.09+5.95 (+1.01%) ▲|MCD235.65+0.42 (+0.18%) ▲|MDLZ61.79+1.38 (+2.28%) ▲|MDT91.93+3.45 (+3.90%) ▲|META742.96+24.29 (+3.38%) ▲|MMM160.89+0.93 (+0.58%) ▲|MO71.66-0.02 (-0.03%) ▼|MRK145.45-0.15 (-0.10%) ▼|MS190.02+0.00 (+0.00%) ▲|MSFT541.15+6.08 (+1.14%) ▲|MU989.04-39.96 (-3.88%) ▼|NEE78.51+1.13 (+1.46%) ▲|NFLX70.61+0.31 (+0.44%) ▲|NKE35.35+0.64 (+1.84%) ▲|NOW140.32-0.54 (-0.38%) ▼|NVDA226.32-2.96 (-1.29%) ▼|ORCL137.39-4.01 (-2.84%) ▼|PEP126.68+0.71 (+0.56%) ▲|PFE28.40+0.12 (+0.42%) ▲|PG153.20+1.97 (+1.30%) ▲|PLTR209.00-0.05 (-0.02%) ▼|PM202.00+0.81 (+0.40%) ▲|QCOM174.43-1.07 (-0.61%) ▼|RTX186.66+0.69 (+0.37%) ▲|SBUX92.29+1.54 (+1.69%) ▲|SCHW97.06+0.36 (+0.37%) ▲|SO87.04+0.87 (+1.01%) ▲|SPG201.41+1.99 (+1.00%) ▲|T22.49+0.31 (+1.40%) ▲|TMO662.24+4.22 (+0.64%) ▲|TMUS151.87+3.29 (+2.21%) ▲|TSLA378.03-4.67 (-1.22%) ▼|TXN281.74-2.00 (-0.70%) ▼|UBER71.50-0.01 (-0.01%) ▼|UNH378.52-0.78 (-0.21%) ▼|UNP281.57+3.23 (+1.16%) ▲|UPS95.34+0.77 (+0.81%) ▲|USB57.42+0.34 (+0.60%) ▲|V389.27+3.82 (+0.99%) ▲|VZ42.78+1.13 (+2.71%) ▲|WFC83.32-0.23 (-0.28%) ▼|WMT113.08+1.73 (+1.55%) ▲|XOM172.15+3.21 (+1.90%) ▲|
17.3 C
New York
Tuesday, October 13, 2026

Tag: news

newssourceFORcompanyinformationcontent1releasesmarket

Global Defense Contractor Burke Products Selects Datavault AI for Enhanced National Defense and Aerospace Technologies Contracts

Datavault AI Selected to Support Mission-Critical Defense and Aerospace Programs in Strategic Partnership with Burke Engineering 
Datavault AI Selected to Support Mission-Critical Defense and Aerospace Programs in Strategic Partnership with Burke Engineering

SASOL LIMITED: PRODUCTION AND SALES METRICS AND TRADING STATEMENT FOR THE YEAR ENDED 30 JUNE 2025

JOHANNESBURG, July 22, 2025 /PRNewswire/ -- Production and sales metrics for the year ended 30 June 2025 Sasol has published its production and sales performance metrics...

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...

SkylineDx’s Merlin Melanoma Assay shows its ability to reduce SLNB by over 40% in a Danish Multicenter Validation Study

In the independent blinded validation study, Merlin accurately identifies melanoma patients at low risk of metastatic disease, including sentinel lymph node metastasis The potential SLNB surgery...

IIHM Reveals First-Ever Hospitality AI Awards, Hosts Landmark Debate on Tech & Human Touch

KOLKATA, India, July 22, 2025 /PRNewswire/ -- The International Institute of Hotel Management (IIHM), India's most internationally recognized hospitality education brand, marked World AI...

Nash Energy and Rincell Corporation Join Hands to Manufacture NMC Cells in India

Highlights Strategic Partnership: Nash Energy and Rincell have signed an MoU to collaborate on sale and manufacturing advanced NMC battery cells in India.Technology Transfer: Rincell will transfer...

AaB genoptager forhandlinger om et salg af Mathias Jørgensen

NASDAQ Copenhagen A/S

Lecanemab four-year efficacy and safety data to be presented at AAIC 2025

STOCKHOLM, July 22, 2025 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present the latest findings on lecanemab (Leqembi®), including...

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CORZ, OLO, GMS on Behalf of Shareholders

NEW YORK, July 22, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of...

Evyve Becomes First Customer to Deploy Tritium’s Revolutionary TRI-FLEX Ultra-Scaling Platform to Meet Rapid Network Growth Demands

Partnership combines Evyve's sustainable charging leadership with Tritium's industry-first lifetime 
Partnership combines Evyve's sustainable charging leadership with Tritium's industry-first lifetime

SNACKS, PEP TALKS, AND SECRET CRIES: SURVEY REVEALS WHAT AUSTRALIANS REALLY DO IN THEIR CARS

BRISBANE, Australia, July 22, 2025 /PRNewswire/ -- New research released today from insurance provider Youi has revealed that for many Australians, their car is...

NBPE – Net Asset Value(s)

THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO AUSTRALIA, CANADA, ITALY, DENMARK, JAPAN, THE UNITED STATES, OR TO ANY NATIONAL OF SUCH JURISDICTIONS

Transaction in Own Shares

Transaction in Own Shares

Bavarian Nordic Receives Acceptance from Health Canada for Review of the New Drug Submission for its Chikungunya Vaccine

COPENHAGEN, Denmark, July 22, 2025 – Bavarian Nordic A/S (OMX: BAVA) announced today that Health Canada has accepted for review the Company’s application for licensure of the single-dose, virus-like particle (VLP) chikungunya vaccine candidate, CHIKV VLP, for immunization to prevent disease caused by chikungunya virus infection in individuals 12 years of age and older. The application screening acceptance by the Directorate confirms that the New Drug Submission is complete and begins a standard review procedure, potentially supporting approval of the vaccine in the first half of 2026.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsNews

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers